Gain Therapeutics (GANX) Competitor Comparison
We are evaluating the key criteria listed to compare Gain Therapeutics (GANX) against its competitors in the Biotechnology industry.
Market Capitalization
276 / 368Gross Profits
157 / 278Total Revenue
276 / 300EBITDA
93 / 337Free Cashflow
85 / 352Quick Ratio
284 / 357Earnings per Share
171 / 359Dividend yield
0 / 6Total Cash
317 / 358Performance 3 years
285 / 368Performance 5 years
305 / 368Performance 10 years
266 / 368Linearity 3 years
189 / 366Linearity 5 years
256 / 368Linearity 10 years
222 / 368Total Rank
318 / 368Dividend Rank
138 / 368Valuation Rank
205 / 368Piotroski Rank
344 / 368Muliplier Rank
349 / 368Linearity 10 years - GANX ranking 222 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.